Abstract
Immunoprotection during most forms of candidiasis (oropharyngeal, invasive) is lacking since most candidiasis patients are immunosuppressed either as a result of their allogeneic transplant, cancer chemotherapy, or HIV infection. Consequently, immunization might be considered as an unlikely way to protect patients from such infection. Nonetheless, there are a number of investigations that indicate active immunization or the passive treatment with hyperimmune, specific antibodies can result in protection in models of experimental candidiasis. The former subject, active immunization, is the subject of this chapter. We focus on recent efforts with the Als family of cell wall proteins to serve as a model, and also offer immunization methods in candidiasis models that can be adapted to any antigen of the organism.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Segal, E. and Elad, D. (2004). Immunizations against fungal diseases in man and animals. In: Handbook of Fungal Biotechnology (Arora, D.K. ed.), Marcel Dekker, Inc., New-York, pp. 503–514.
Casadevall, A. (2002). Acquired immunity against fungi. In: Immunology of Infectious Diseases (Kaufman, S., Sher, A., Ahmed, R. eds.), ASM Press, Washington D.C., pp. 223–234.
Deepe, G. (2004). Preventative and therapeutic vaccines for fungal infections: from concept to implementation. Expert Rev. Vaccines 3, 1–9.
Cassone, A., De Bernardis, F. and Torososantucci, A. (2005). An outline of the role of anti-Candida antibodies in the context of passive immunization and protection from candidiasis. Curr. Mol. Med. 5, 377–382.
Magliani, W., Conti, S., Cassone, A., De Bernardis, F. and Polonelli, L. (2002) New immunotherapeutic strategies to control vaginal candidiasis. Trends Mol. Med. 8, 121–126.
Edwards, J.E. (2005) Candida species. In: Principles and Practice of Infectious Diseases (Mandell, G.L., Bennett, J.E., Dolin, R., eds.), 6th Ed, Churchill Livingstone, Philadelphia, pp. 2938–2956.
Segal, E. and Elad, D. (2005). Candidiasis. In: Topley and Wilson's Microbiology and Microbial Infections (Merz, W.G., Hay, R., eds.), 10th Ed, Arnold, London, pp. 579–623.
Levy, R., Segal, E., and Eylan, E. (1981) Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions. Infect. Immun. 31, 874–878.
Segal, E. and Sandovsky-Losica, H. (1981) Experimental vaccination with Candida albicans ribosomes in cyclophosphamide treated animals. Sabouraudia 19, 267–274.
Levy, R., Segal, E., Eylan, E. and Barr-Nea, L. (1983) Cell-mediated immunity following experimental vaccinations with Candida albicans ribosomes. Mycopathologia 83, 161–168.
Levy, R., Segal, E. and Eylan, E. (1984) Detection of antibodies against Candida albicans ribosomes by the enzyme linked immunosorbent assay. Mycopathologia 87, 167–170.
Segal, E., Nussbaum, S. and Barr-Nea, L. (1985) Protection against systemic infections with various Candida species elicited by vaccination with Candida albicans ribosomes. J. Med. Vet. Mycol. 235, 275–285.
Segal, E., Sandovsky-Losica, H. and Nussbaum, S. (1985) Immune responses elicited by Candida albicans ribosomes in cyclophosphamide treated animals. Mycopathologia 89, 113–118.
Levy, R. and Segal, E. (1986) Induction of candicidal activity in mice by immunization with Candida albicans ribosomes. FEMS Microbiol. Lett. 36, 213–217.
Segal, E., Spongin, A., Levy, R. and Barr-Nea, L. (1987) Induction of protection against candidiasis in tumor bearing mice by vaccination with Candida albicans ribosomes. J. Med. Vet. Mycol. 25, 355–363.
Eckstein, M., Barenholtz, Y. and Segal, E. (1997) Liposomes containing Candida albicans ribosomes as prophylactic vaccine against disseminated candidiasis in mice. Vaccine 15, 220–224.
Ibrahim, A.S., Spellberg, B.J., Avenissian, V., Fu, Y., Filler, S.G. and Edwards, J.E., Jr. (2005) Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect. Immun. 73, 999–1005.
Ibrahim, A.S., Spellberg, B.J., Avenissian, V., Fu, Y. and Edwards, J.E., Jr. (2006) The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis. Infect. Immun. 74, 3039–3041.
Spellberg, B.J., Ibrahim, A.S., Avenasian, V., Fu, Y., Myers, C., Phan, Q.T., Filler, S.G., Yeaman, M.R. and Edwards, J.E. (2006). Efficacy of anti-Candida rAls3p-N or Alsp-N vaccines against disseminated and mucosal candidiasis. J. Infect. Dis. 194, 256–260.
De Bernardis, F., Lorenzini, R. and Cassone, A. (1999). Rat model of Candida vaginal infection. In: Handbook of Animal Models in Infection (Zak, O, Sande, M.A. eds.), Academic Press, New York, pp. 735–740.
Cardenas-Freytag, L., Steele, C., Wormley, F.L., Cheng, E., Clements, J.R. and Fidel, J.R. (2002). Partial protection against experimental candidiasis after mucosal vaccination with heat killed Candida albicans and mucosal adjuvant LT (R192G). Med. Mycol. 40, 291–299.
De Bernardis, F., Boccanera, M., Adriani, D., Girolamo, A. and Cassone, A. (2002). Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis. Infect. Immun. 70, 2725–2729.
Segal, E., Baranetz, T., Sandovsky-Losica, H., Gov, Y., Teicher, S. and Dayan, D. (1999). Experimental oral murine candidiasis and attempts of prevention. J. Med. Mycol. 9, 10–15.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Segal, E., Sandovsky-Losica, H. (2009). Immunization Protocols for Use in Animal Models of Candidiasis. In: Cihlar, R.L., Calderone, R.A. (eds) Candida albicans. Methods in Molecular Biology, vol 499. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-151-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-60327-151-6_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-760-0
Online ISBN: 978-1-60327-151-6
eBook Packages: Springer Protocols